> Boston Scientific ($BSX) plans to fight an IRS notice that says the company owes an additional $581 million in taxes, plus interest and penalties. Report
> Ex-Olympus CEO Michael Woodford will meet with lawmakers in Tokyo to lobby for reforms to Japanese boardrooms. The camera and endoscope maker has been embroiled in one of Japan's worst accounting frauds. News
> MELA Sciences ($MELA) has named several new directors to serve on its board--Robert Coradini, Mark Fabiani, John Goddard, James Noble and David Stone. MELA release
> Zimmer Holdings ($ZMH) has announced the availability of its CLS Brevius hip stem with Kinectiv technology in the U.S. that enables surgeons to better match patients' individual anatomies with modular neck options designed for independent, intraoperative adjustments. Zimmer release
> Soteira has received the 510(k) clearance of the Shield kyphoplasty system. "With the addition of the Shield to the existing Soteira portfolio and an active short-cycle pipeline, we are continuing to work toward offering the most comprehensive product portfolio for VCF treatment in the global market," President and CEO Larry Jasinski explained. Soteira statement
And Finally... Mark Cain, CTO of MIM Software, was invited onstage at Apple's Worldwide Developer Conference in 2008 to promote his company's iPhone app, a way for doctors to view incredibly detailed scans of their patients. However, two months after the demo, the FDA told MIM Software to remove the app from Apple's store, saying it needed to be cleared. Now Cain is seeing a lot of apps being bought and sold without FDA supervision. Report